Roxana Mehran, M.D., FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: medicines company(MODEST), Medscape(MODEST), The Medicines Company(MODEST), Boston Scientific(MODEST), Merck & Co., Inc.(MODEST), Cardiovascular Systems Inc(MODEST), Shanghai BraccoSine Pharmaceutical Corp(MODEST), AstraZeneca Pharmaceuticals(MODEST) RESEARCH/RESEARCH GRANTS: The Medicines Company(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Eli Lilly/DSI(SIGNIFICANT), OrbusNeich(NONE), Bristol-Myers Squibb Company (SIGNIFICANT), CSL Behring (SIGNIFICANT), Abbott Vascular(SIGNIFICANT), Watermark Research Partners(SIGNIFICANT), Novartis Pharmaceuticals(SIGNIFICANT), Medtronic(SIGNIFICANT), AUM Cardiovascular Inc.(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Wiley Blackwell Publishing Company(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Osprey Medical(MODEST)

View Full Disclosure